Answers are grounded in this paper and cite their sources.
This phase 2 trial involving patients with NASH showed that treatment with semaglutide resulted in a significantly higher percentage of patients with NASH resolution than placebo. However, the trial did not show a significant between-group difference in the percentage of patients with an improvement in fibrosis stage. (Funded by Novo Nordisk; ClinicalTrials.gov number, NCT02970942.).
No takes yet. Share an insight, caveat, or question.
Newsome et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: